XML 33 R21.htm IDEA: XBRL DOCUMENT

Note 4 - Acquisition (Tables)

6 Months Ended

Jun. 30, 2016

Notes Tables

Business Combination, Preliminary Purchase Price Consideration [Table Text Block]

Purchase consideration
Fair value of RestorGenex shares outstanding		$	19,546,000
Estimated fair value of RestorGenex stock options assumed by Diffusion			1,321,000
Estimated fair value of RestorGenex warrants assumed by Diffusion			384,000
CVRs – RES-440 product candidate			10,000
Total preliminary purchase price		$	21,261,000

Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]

Cash and cash equivalents		$	8,500,602
Prepaid expenses and other assets			195,200
Property and equipment			57,531
Intangible assets			9,317,000
Goodwill			7,105,031
Accrued liabilities			(377,431	)
Deferred tax liability			(3,536,933	)
Net assets acquired		$	21,261,000

Schedule of Finite-Lived Intangible Assets [Table Text Block]

		June 30, 2016												December 31, 2015
		Gross Carrying Amount				Accumulated Amortization				Intangible Assets, net				Gross Carrying Amount				Accumulated Amortization				Intangible Assets, net
RES 529		$	8,385,000			$	0			$	8,385,000			$	0			$	0			$	0
RES-440			932,000				0				932,000				0				0				0
Total in-process research and development costs (IPR&D)		$	9,317,000			$	0			$	9,317,000			$	0			$	0			$	0

Business Acquisition, Pro Forma Information [Table Text Block]

		Three Months Ended June 30,								Six Months Ended June 30,
		2016				2015				2016				2015
Net revenues		$	—			$	—			$	—			$	—
Net loss		$	(3,806,194	)		$	(5,300,450	)		$	(8,464,138	)		$	(10,060,351	)
Basic and diluted loss per share		$	(0.04	)		$	(0.13	)		$	(0.08	)		$	(0.24	)